Article info
PDFCardiac risk factors and prevention
Original research article
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
- Correspondence to Dr Stephen F Weng; stephen.weng{at}nottingham.ac.uk
Citation
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
Publication history
- Received March 27, 2015
- Revision received July 17, 2015
- Accepted August 4, 2015
- First published August 21, 2015.
Online issue publication
April 30, 2020
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/